Mid-Cap Pharma Stock Jumps 10.77% as China Subsidiary Secures Drug Manufacturing License!

 🔹Summary

Dishman Carbogen Amcis Limited has announced that its wholly-owned subsidiary, Carbogen Amcis (Shanghai) Co. Ltd., has received a Drug Manufacturing License from the National Medical Product Administration (NMPA) for its Shanghai facility in China. This approval marks a significant milestone in the company's global pharmaceutical operations.

📊Stock Performance

  • Following the order announcement, Dishman Carbogen Amcis Limited stock share price surged by 10.77%, reaching an intraday high of Rs.208.10.
  • Market Capitalization: Rs.3,223.77 Crore.


🧾 Key Development Details

  • Subsidiary: Carbogen Amcis (Shanghai) Co. Ltd.

  • Approval Received: Drug Manufacturing License

  • Issued By: National Medical Product Administration, China

  • Purpose: Enables manufacturing of pharmaceutical products at the Shanghai facility

🏢 About the Company

Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries.

📢 Disclaimer

The content provided by Equity Insights Hub is for educational and informational purposes only. It should not be considered as financial or investment advice. Investors are advised to consult a SEBI-registered financial advisor before making investment decisions. We are not liable for any financial losses.

📬 Follow Equity Insights Hub for real-time market movers, global pharma news, and stock-specific updates!


Comments

Post a Comment

Popular Stocks

BHEL Shares Rise 3.48% After Securing Rs.7,500 Crore EPC Contract from GSECL

Image
Summary: Bharat Heavy Electricals Limited (BHEL) has received a Letter of Intent (LOI) from Gujarat State Electricity Corporation Limited (GSECL) for the EPC package of the 1x800 MW Ukai Extension Unit No. 7 Thermal Power Station (TPS) in Tapi District, Gujarat . The contract includes supply, erection, commissioning, and civil works. The order is valued at approximately Rs . 7,500 crore (excluding taxes & duties). Stock Performance: The stock surged 3.48% intraday , reaching a high of ₹213.65 following the announcement. Market Cap : Rs . 74,098.31 Cr. Key Data Points: Company: Bharat Heavy Electricals Limited (BHEL) Order Value:  Rs7,500 crore (excluding taxes & duties) Client: Gujarat State Electricity Corporation Limited (GSECL) Project: 1x800 MW Ukai Extension Unit No. 7 Thermal Power Station (TPS) Location: Tapi District, Gujarat Scope of Work: Supply of Equipment: Boiler, Turbine, Generator, and associated auxiliaries Balance of Plant (BoP) Package...
Read more